prussian blue Radiogardase
Selected indexed studies
- Nanosized Prussian blue and its analogs for bioimaging and cancer theranostics. (Acta Biomater, 2024) [PMID:38176673]
- Prussian blue: from advanced electrocatalyst to nanozymes defeating natural enzyme. (Mikrochim Acta, 2022) [PMID:35879483]
- Silver Prussian blue analogue nanomedicine for future cancer therapy. (Future Oncol, 2021) [PMID:33244991]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Nanosized Prussian blue and its analogs for bioimaging and cancer theranostics. (2024) pubmed
- Prussian blue: from advanced electrocatalyst to nanozymes defeating natural enzyme. (2022) pubmed
- Silver Prussian blue analogue nanomedicine for future cancer therapy. (2021) pubmed
- Prussian Blue: A Nanozyme with Versatile Catalytic Properties. (2021) pubmed
- Prussian blue nanozymes: progress, challenges, and opportunities. (2023) pubmed
- Advancements of Prussian blue-based nanoplatforms in biomedical fields: Progress and perspectives. (2022) pubmed
- Prussian blue nanoparticles and their analogues for application to cancer theranostics. (2016) pubmed
- Progress in Applications of Prussian Blue Nanoparticles in Biomedicine. (2018) pubmed
- Oral formulation of Prussian blue with improved efficacy for prophylactic use against thallium. (2023) pubmed
- Prussian blue nanoparticles: synthesis, surface modification, and biomedical applications. (2020) pubmed